- VXRT -1.60%
While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the most
Yahoo Finance · 5 days ago
Open | 0.6609 |
High | 0.6650 |
Low | 0.6600 |
Mkt Cap | 117.99M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 0.6758 |
52 Wk. Low | 0.5200 |
52 Wk. High | 1.5400 |
Related stocks
American biotechnology company based in San Francisco
Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 2.18M | 223.10% ▲ |
Net Income | -24.42M | - |
Diluted EPS | -0.14 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.03 | - |
Q1 2024 | -$0.14 | -$0.14 |
Q4 2023 | -$0.14 | -$0.12 |
S&P 500^GSPC | 5,476.94-0.96 (-0.02%) |
Dow 30^DJI | 39,064.81-62.99 (-0.16%) |
Nasdaq^IXIC | 17,819.34+14.18 (+0.08%) |
134.44-5.56% | |
12.69-18.97% | |
Amazon.com, Inc.AMZN | 195.24+0.84% |